Table:
begin	end	state
1	28	non-cytoplasmic
29	49	transmembrane
50	60	cytoplasmic
61	80	transmembrane
81	99	non-cytoplasmic
100	125	transmembrane
126	161	cytoplasmic
162	181	transmembrane
182	186	non-cytoplasmic
187	206	transmembrane
207	265	cytoplasmic
266	287	transmembrane
288	301	non-cytoplasmic
302	328	transmembrane
329	339	cytoplasmic
340	358	transmembrane
359	363	non-cytoplasmic
364	385	transmembrane
386	392	cytoplasmic
393	420	transmembrane
421	425	non-cytoplasmic
426	447	transmembrane
448	458	cytoplasmic

Input:
>BPHYT_RS22690 FitnessBrowser__BFirm:BPHYT_RS22690
MQQPIQSSSADAATPQGVTASTARRSKARYQILALLAVGTMINYLDRTVLGIAAPQLTKE
LGINAALMGLLFSVFSWSYVASQIPGGLFLDRFGSKLTYFLSMTLWSLCTLAQGLVHGIG
ALFAFRLGLGVSEAPCFPTNSRVVATWFPQSERAMATGTYTVGEYIGLAFFSPFLFMLMG
AFGWRSLFYVVGGVGIVFGGIWWMFYREPRDHPSANQAELDYIEAGGGLTHRKKDADSAG
GADAASAKSGGFEWRTIGRLLKHRQLTGICLGQFAGNSTLVFFLTWFPTYLATERHMAWL
KIGFFAIMPFIAASIGVMFGGFFSDWLLRRGKSPNVARKLPIIAGLLLASTIILANYVES
NVAVIAILSVAFFAQGMAALGWTLVSDIAPDGLLGVTGGIFNFAANLAGIVTPLVVGFIV
AATGSFVGALVFIGAIALIGALSYIFIVGDIKRIVLVD

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server